The number of men diagnosed with BPH progressively increases with age. By 60 years of age, approximately 50% of all men will develop some signs of BPH, which will require treatment.
Symptoms of BPH include slowness or dribbling of urinary stream, hesitancy or difficulty starting urination, frequent urination, feeling of urgency and/or sudden need to urinate and the need to get up in the middle of the night to urinate.
There are many treatment options available for BPH including medication, surgery and minimally invasive treatments including UroLift, Transurethral Microwave Therapy (TUMT), Transurethral Needle Ablation (TUNA) and Intraurethral Stents.
The UroLift System is a straightforward procedure that utilizes tiny implants to lift and hold the enlarged prostate tissue out of the way so it no longer blocks the urethra. There is no cutting, heating or removal of prostate tissue.
Clinical data has proven that UroLift System treatment is safe and effective and can improve BPH symptoms 3-4 times greater than with medication. Results have shown durability to two years with no impact to sexual function. The goal is to relieve you of bothersome urinary symptoms so you can get back to life and resume daily activities.
Most common adverse reported events include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure.
The UroLift System consists of a delivery device and permanent implants. The implants are delivered during a minimally invasive treatment and act like window curtain tie-backs, holding the lobes of the enlarged prostate open to relieve obstruction. No cutting, heating, or removing prostate tissue is involved.
The UroLift System is a treatment option for BPH patients who are looking for an alternative to drugs or major surgery. You may be considering surgical options and/or are unhappy with or have stopped taking medications. The UroLift System is appropriate for patients seeking a minimally invasive treatment and are concerned about preserving their sexual function and their quality of life, post-treatment.
Patients may experience improvement in their lower urinary tract symptoms as early as 2 weeks after the procedure.
There have been no reports of erectile dysfunction or ejaculatory dysfunction as a result of the UroLift System treatment.
There is minimal downtime post-procedure and patients may experience symptom relief in as early as 2 weeks. Typically, no overnight stay and no catheter is required but you may experience urinary discomfort during the recovery period. Your doctor will discuss with you how quickly you can return to your daily activities.
There is a large amount of data from clinical studies conducted in the US, Canada, Europe and Australia that has been presented in peer-reviewed medical publications demonstrating the safety and effectiveness of the UroLift System.
Contact Us |
Patient Portal |
© 2011 Western New York Urology Associates. Western New York Urology Associates, Cancer Care of Western New York, Main Urology Associates, and associated logos are service marks of Western New York Urology Associates, LLC. RapidArc and all other trademarks and service marks are the property of their respective owners.